Key result
A recombinant infectious bursal disease virus strain (BD-3tcC) with four amino acid substitutions in VP2 was successfully generated and demonstrated in vitro replication similar to cell-culture-adapted strains.
A recombinant IBDV with four specific VP2 mutations was successfully generated via reverse genetics, providing a tool for future studies on viral pathogenicity.
Provides a reverse-genetics platform for IBDV VP2 studies; leaves open in vivo pathogenicity and any vaccine implications.
Infectious bursal disease virus (IBDV), a virus with a double-stranded, bi-segmented RNA genome, is an economically important pathogen of chickens. Recent understanding of the molecular biology of IBDV has implicated several amino acid residues in the capsid protein VP2 in pathogenicity and tissue culture adaptation. In the present study a recombinant strain of IBDV having four mutations in VP2 (Gln253His, Asp279Asn, Ala284Thr and Ser330Arg) has been generated using reverse genetics. Desired mutations were introduced in the VP2 gene of the cloned cDNA of genome segment A of a very virulent (vv) IBDV by site-directed mutagenesis. Capped RNA transcribed in vitro from cloned cDNA of the modified segment A and wild type segment B was co-transfected into chicken embryo fibroblast (CEF) cell culture. The recombinant virus, designated as BD- 3tcC, was rescued from the transfected cell culture and characterized in vitro. BD-3tcC retained all the four desired mutations and replicated with titres only slightly lower than those of CEF cell-culture-adapted wild-type IBDV. This recombinant strain can be used in future studies for understanding the biological significance of these four amino acid residues in VP2. DOI: http://dx.doi.org/10.3329/bvet.v31i1.22838 Bangl. vet. 2014. Vol. 31, No. 1, 12-19
No takes yet. Share an insight, caveat, or question.
Noor et al. (2015) studied Infectious bursal disease virus (IBDV). Recombinant IBDV strain BD-3tcC vs. BD-3tc and Cu-1 strains was evaluated on In vitro growth kinetics and plaque morphology. A recombinant infectious bursal disease virus strain (BD-3tcC) with four amino acid substitutions in VP2 was successfully generated and demonstrated in vitro replication similar to cell-culture-adapted strains.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: